ATE425763T1 - Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose - Google Patents

Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose

Info

Publication number
ATE425763T1
ATE425763T1 AT03722171T AT03722171T ATE425763T1 AT E425763 T1 ATE425763 T1 AT E425763T1 AT 03722171 T AT03722171 T AT 03722171T AT 03722171 T AT03722171 T AT 03722171T AT E425763 T1 ATE425763 T1 AT E425763T1
Authority
AT
Austria
Prior art keywords
treatment
sarcoidosis
peptides
vasoactive intestinal
compositions
Prior art date
Application number
AT03722171T
Other languages
English (en)
Inventor
Dorian Bevec
Original Assignee
Mondobiotech Licensing Out Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mondobiotech Licensing Out Ag filed Critical Mondobiotech Licensing Out Ag
Application granted granted Critical
Publication of ATE425763T1 publication Critical patent/ATE425763T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03722171T 2002-06-10 2003-06-05 Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose ATE425763T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012767 2002-06-10

Publications (1)

Publication Number Publication Date
ATE425763T1 true ATE425763T1 (de) 2009-04-15

Family

ID=29724383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722171T ATE425763T1 (de) 2002-06-10 2003-06-05 Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose

Country Status (13)

Country Link
US (2) US20060241028A1 (de)
EP (1) EP1515745B1 (de)
JP (1) JP2005535607A (de)
CN (2) CN1313149C (de)
AT (1) ATE425763T1 (de)
AU (1) AU2003236072B2 (de)
BR (1) BR0305039A (de)
CA (1) CA2488358A1 (de)
DE (1) DE60326723D1 (de)
DK (1) DK1515745T3 (de)
HK (1) HK1080363B (de)
NO (1) NO330954B1 (de)
WO (1) WO2003103702A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004255379B2 (en) 2003-07-14 2007-08-16 Mondobiotech Ag Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
WO2007073486A2 (en) 2005-12-20 2007-06-28 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) * 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
CN102131516B (zh) 2008-06-27 2016-03-16 杜克大学 包含弹性蛋白样肽的治疗剂
CN101434649B (zh) * 2008-12-12 2012-04-25 余榕捷 一种环七肽及其制备方法和应用
US9029505B2 (en) 2009-08-14 2015-05-12 Phasebio Pharmaceuticals, Inc. Modified vasoactive intestinal peptides
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US11052132B2 (en) 2014-05-08 2021-07-06 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
CN114652817B (zh) 2015-02-09 2026-04-17 费斯生物制药公司 用于治疗肌肉疾病和病症的方法和组合物
US12411144B2 (en) * 2017-03-22 2025-09-09 Children's Hospital Medical Center Compositions and methods for treatment of lung function
EP3583933A1 (de) 2018-06-20 2019-12-25 Albert-Ludwigs-Universität Freiburg Verabreichung von aviptadil durch inhalation zur behandlung von chronischer berylliumkrankheit
CA3138891A1 (en) 2019-05-07 2020-11-12 Advita Lifescience Gmbh Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis
CN115066254A (zh) * 2020-01-31 2022-09-16 阿德维塔生命科学有限责任公司 用于吸入治疗炎症性肺病的人抗炎肽
US20230381280A1 (en) 2020-12-04 2023-11-30 Centurion Ilaç Sanayi Ve Ticaret Anonim Sirketi New dosage regimen for inhaled vasoactive intestinal polypeptide
WO2022224172A1 (en) * 2021-04-20 2022-10-27 Advita Lifescience Ag Use of aviptadil alone or in combination with alpha lipoic acid as a therapeutic medicament for post-viral infection syndrome

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3898329A (en) * 1971-09-17 1975-08-05 Sami I Said Vasoactive intestinal peptide, composition and method
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4237046A (en) 1979-04-27 1980-12-02 Miklos Bodanszky Polypeptides and methods of preparation
GB8427651D0 (en) 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4745100A (en) 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
GB8525852D0 (en) 1985-10-19 1985-11-20 Beecham Group Plc Compounds
GB8729802D0 (en) 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
SE8705139D0 (sv) 1987-12-23 1987-12-23 Trion Forskning & Utveckling Forfarande for framstellning av ett stort antal peptidanaloger och nya peptidanaloger
WO1990006952A1 (fr) 1988-12-22 1990-06-28 Kirin-Amgen, Inc. Facteur de stimulation de colonies de granulocytes modifies chimiquement
US5141924A (en) 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
JPH04193896A (ja) 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
DE69101187T2 (de) 1990-06-26 1994-09-29 Sanwa Kagaku Kenkyusho Co VIP-Analogen und ihre Verwendung.
AU656230B2 (en) 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
JPH06220090A (ja) 1993-01-22 1994-08-09 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
JPH07173197A (ja) 1993-12-20 1995-07-11 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド修飾化合物及びその用途
JPH10502333A (ja) 1994-04-07 1998-03-03 プロティーンニックス カンパニー バソアクティブ・インテスティナル・ポリペプチド
CN1186355C (zh) 1996-02-09 2005-01-26 霍夫曼-拉罗奇有限公司 血管活性肠肽类似物的合成
EP0914094A4 (de) 1996-03-28 2000-03-01 Univ Illinois Materialen und verfahren zur herstellung verbesserter liposomaler mittel
EP0985671B1 (de) * 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN
US6217886B1 (en) * 1997-07-14 2001-04-17 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
PL345583A1 (en) * 1998-07-20 2001-12-17 Sod Conseils Rech Applic Peptide analogues of pacap
AU7352200A (en) * 1999-09-01 2001-03-26 Regents Of The University Of California, The Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons
EP1233811A2 (de) * 1999-11-12 2002-08-28 Leo Rubin Verfahren zur behandlung von herzstillstand oder pulmonarer hypertension und substanzen zur verwendung dafür mit vasoaktivem intestinalen polypeptid und kardiales gerät zur elektrischen und chemischen regulation sowie verwendungsverfahren dafür
AU2072002A (en) * 2000-11-28 2002-06-11 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension

Also Published As

Publication number Publication date
US20080274961A1 (en) 2008-11-06
WO2003103702A1 (en) 2003-12-18
HK1080363A1 (en) 2006-04-28
AU2003236072B2 (en) 2008-10-23
NO20040488L (no) 2004-04-07
BR0305039A (pt) 2004-11-09
DK1515745T3 (da) 2009-07-13
CN101015679A (zh) 2007-08-15
CN1313149C (zh) 2007-05-02
DE60326723D1 (de) 2009-04-30
US7951778B2 (en) 2011-05-31
EP1515745A1 (de) 2005-03-23
HK1080363B (zh) 2007-12-21
JP2005535607A (ja) 2005-11-24
US20060241028A1 (en) 2006-10-26
EP1515745B1 (de) 2009-03-18
AU2003236072A1 (en) 2003-12-22
NO330954B1 (no) 2011-08-22
CN1658896A (zh) 2005-08-24
CA2488358A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
DE60326723D1 (de) Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
WO2002043746A3 (en) Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
US9060991B2 (en) Use of GLP-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission
JP5670190B2 (ja) 機能障害性シナプス伝達に伴う障害の治療用ｇｉｐの使用
AU2017216533A1 (en) Improved peptide pharmaceuticals
CN102711802A (zh) 肽glp-2激动剂
SK82096A3 (en) Compounds influencing growth hormone releasing
ATE496060T1 (de) Proteinartige verbindungen und anwendungen davon
JP2024054222A (ja) 活性薬剤の経口投与のための製剤
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
JPH10512280A (ja) ＰＴＨおよびＰＴＨｒＰの環式同族体
JP2006506942A5 (de)
PT981362E (pt) Metodos de melhoramento do funcionamento do tracto gastrointestinal superior
CN1917898B (zh) 用于治疗间质肺部感染的血管活性肠肽的生物活性物质
MX2022008748A (es) Administración oral de péptidos.
JP2012500284A (ja) ペプチド性ｐｔｈ受容体アゴニスト
ITMI912582A1 (it) Mutanti dell'ormone della crescita umano e loro impiego
ES2291372T3 (es) Agonistas y antagonistas de urotensina-ii.
ATE234624T1 (de) Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva
TW201000117A (en) Preparation of a pharmaceutical composition for increasing bone mineral density
ATE276273T1 (de) Vip-analoge
CN1916025A (zh) 甲状旁腺素类似物
HK1183798A (en) Methods for treating or preventing vascular graft failure
TH50339B (th) การสมานรอยหักของกระดูกโดยใช้อานาลอกของ PTHrP

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1515745

Country of ref document: EP

EEIH Change in the person of patent owner